More on HELP

- Summary
- Chart
- Profile
- Historical

Data

- Ratings (10.0 Score)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:HELP)
Delayed: 7.70 +0.08 (1.05%)
Prev. Close $7.62  
Open$7.82 
52 Wk High$ 
52 Wk Low$ 
Day High$8.04 
Day Low$7.67 
P/E N/A  
EPS$ 
Volume1,013,383 

Friends, Peers and Foes (?): CYBN, CMPS, DFTX, GHRS JNJ (more...)

Jul 27, 2026 06:55 AM Wells Fargo sees psychedelics market reaching $11B by 2035
Jul 27, 2026 05:44 AM Wells Fargo Starts Cybin Inc. (HELP) at Overweight
Jul 22, 2026 06:52 AM H.C. Wainwright Reiterates Buy Rating on Helus Pharma (HELP)
Jul 21, 2026 05:16 PM Form 6-K CYBIN INC. For: Jul 21
Jul 21, 2026 10:55 AM Helus Pharma completes enrollment in phase 3 depression study
Jul 21, 2026 10:55 AM Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
Jul 21, 2026 07:50 AM Helus Pharma completes enrollment in Phase 3 depression study
Jul 21, 2026 07:50 AM Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
Jul 17, 2026 07:05 AM Helus Pharma (HELP) PT Lowered to $45 at Guggenheim
Jul 16, 2026 03:17 PM Form 6-K CYBIN INC. For: Jun 26
View All Articles

Entities mentioned with HELP

View All Entities